XML 11 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Balance Sheets - USD ($)
Nov. 30, 2015
Feb. 28, 2015
CURRENT ASSETS    
Cash and cash equivalents $ 264,917 $ 257,820
Notes receivable 125,000
Prepaid expenses 121,154 $ 38,748
Total Current Assets 511,071 296,568
Equipment (net of accumulated depreciation of $145,630 and $96,089, respectively) 520,818 526,606
Refundable deposits 43,600 $ 278,952
Deferred offering costs 151,566
TOTAL ASSETS 1,227,055 $ 1,102,126
Current liabilities    
Accounts payable 354,064 293,152
Accrued expenses $ 202,915 4,565
Current portion of capital lease $ 99,965
Note payable (net of discount $354,323) $ 1,076,552
Accrued interest payable 32,000 $ 2,351
Accrued dividends on Series B Preferred Stock 47,369 16,767
Total Current Liabilities $ 1,712,900 416,800
Capital lease 169,676
Derivative warrant liability $ 300,151 273,000
TOTAL LIABILITIES 2,013,051 859,476
STOCKHOLDERS' (DEFICIT) EQUITY    
Common Stock, ($0.0001 par value; 150,000,000 shares authorized; 1,851,201 and 1,831,483 shares issued and outstanding as of November 30, 2015 and February 28, 2015, respectively) 185 183
Additional Paid-in-capital 21,509,931 18,965,529
Accumulated deficit (22,296,199) (18,723,149)
Total stockholders' (deficit) equity (785,996) 242,650
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY 1,227,055 1,102,126
Series A Preferred Stock [Member]    
STOCKHOLDERS' (DEFICIT) EQUITY    
Convertible Preferred Stock: Series A convertible preferred stock ($0.0001 par value; 1,000,000 shares authorized; 874,257 shares issued and outstanding as of November 30, 2015 and February 28, 2015, respectively); Series B convertible preferred stock ($0.0001 par value; 1,000 shares authorized; 646 and 229 shares issued and outstanding as of November 30, 2015 and February 28, 2015, respectively) $ 87 $ 87
Series B Preferred Stock [Member]    
STOCKHOLDERS' (DEFICIT) EQUITY    
Convertible Preferred Stock: Series A convertible preferred stock ($0.0001 par value; 1,000,000 shares authorized; 874,257 shares issued and outstanding as of November 30, 2015 and February 28, 2015, respectively); Series B convertible preferred stock ($0.0001 par value; 1,000 shares authorized; 646 and 229 shares issued and outstanding as of November 30, 2015 and February 28, 2015, respectively)